title: Linking changes in epithelial morphogenesis to cancer mutations using computational modeling.
abstract: Most tumors arise from epithelial tissues, such as mammary glands and lobules, and their initiation is associated with the disruption of a finely defined epithelial architecture. Progression from intraductal to invasive tumors is related to genetic mutations that occur at a subcellular level but manifest themselves as functional and morphological changes at the cellular and tissue scales, respectively. Elevated proliferation and loss of epithelial polarization are the two most noticeable changes in cell phenotypes during this process. As a result, many three-dimensional cultures of tumorigenic clones show highly aberrant morphologies when compared to regular epithelial monolayers enclosing the hollow lumen (acini). In order to shed light on phenotypic changes associated with tumor cells, we applied the bio-mechanical IBCell model of normal epithelial morphogenesis quantitatively matched to data acquired from the non-tumorigenic human mammary cell line, MCF10A. We then used a high-throughput simulation study to reveal how modifications in model parameters influence changes in the simulated architecture. Three parameters have been considered in our study, which define cell sensitivity to proliferative, apoptotic and cell-ECM adhesive cues. By mapping experimental morphologies of four MCF10A-derived cell lines carrying different oncogenic mutations onto the model parameter space, we identified changes in cellular processes potentially underlying structural modifications of these mutants. As a case study, we focused on MCF10A cells expressing an oncogenic mutant HER2-YVMA to quantitatively assess changes in cell doubling time, cell apoptotic rate, and cell sensitivity to ECM accumulation when compared to the parental non-tumorigenic cell line. By mapping in vitro mutant morphologies onto in silico ones we have generated a means of linking the morphological and molecular scales via computational modeling. Thus, IBCell in combination with 3D acini cultures can form a computational/experimental platform for suggesting the relationship between the histopathology of neoplastic lesions and their underlying molecular defects.
authors.affiliation: Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States of America. Kasia.Rejniak@moffitt.org
authors.forename: Katarzyna A
authors.initials: KA
authors.lastname: Rejniak
authors.forename: Shizhen E
authors.initials: SE
authors.lastname: Wang
authors.forename: Nicole S
authors.initials: NS
authors.lastname: Bryce
authors.forename: Hang
authors.initials: H
authors.lastname: Chang
authors.forename: Bahram
authors.initials: B
authors.lastname: Parvin
authors.forename: Jerome
authors.initials: J
authors.lastname: Jourquin
authors.forename: Lourdes
authors.initials: L
authors.lastname: Estrada
authors.forename: Joe W
authors.initials: JW
authors.lastname: Gray
authors.forename: Carlos L
authors.initials: CL
authors.lastname: Arteaga
authors.forename: Alissa M
authors.initials: AM
authors.lastname: Weaver
authors.forename: Vito
authors.initials: V
authors.lastname: Quaranta
authors.forename: Alexander R A
authors.initials: AR
authors.lastname: Anderson
mesh_terms: D017209:Apoptosis / Q000235:genetics; D001943:Breast Neoplasms / Q000235:genetics*; D049109:Cell Proliferation; D003198:Computer Simulation; D004848:Epithelium / Q000254:growth & development*; D005109:Extracellular Matrix / Q000235:genetics; D005260:Female; D006801:Humans; D042361:Mammary Glands, Human / Q000033:anatomy & histology / Q000254:growth & development / Q000502:physiology*; D008954:Models, Biological; D009024:Morphogenesis / Q000235:genetics*; D009154:Mutation; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human